Filing Details
- Accession Number:
- 0001104659-20-134811
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-11 17:01:14
- Reporting Period:
- 2020-12-10
- Accepted Time:
- 2020-12-11 17:01:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1561958 | Yann Echelard | 2 Gansevoort Street, 9Th Floor New York NY 10014 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-10 | 30,000 | $40.05 | 129,116 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average sales price. The range of prices for such transaction was $39.90 to $40.13. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes shares of restricted Common Stock, which vest over various time periods.
Billionaire Hedge Funds
